Gensight Biologics Sa Stock Number Of Employees
| GSGTF Stock | USD 0.45 0.00 0.00% |
GenSight Biologics SA fundamentals help investors to digest information that contributes to GenSight Biologics' financial success or failures. It also enables traders to predict the movement of GenSight Pink Sheet. The fundamental analysis module provides a way to measure GenSight Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GenSight Biologics pink sheet.
GenSight |
GenSight Biologics SA Company Number Of Employees Analysis
GenSight Biologics' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current GenSight Biologics Number Of Employees | 44 |
Most of GenSight Biologics' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GenSight Biologics SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, GenSight Biologics SA is currently employing 44.0 people. This is 99.6% lower than that of the Healthcare sector and 91.78% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.77% higher than that of the company.
GenSight Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GenSight Biologics' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GenSight Biologics could also be used in its relative valuation, which is a method of valuing GenSight Biologics by comparing valuation metrics of similar companies.GenSight Biologics is currently under evaluation in number of employees category among related companies.
GenSight Fundamentals
| Return On Equity | -1.72 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (6.59) % | |||
| Current Valuation | 131.61 M | |||
| Shares Outstanding | 46.16 M | |||
| Shares Owned By Insiders | 12.75 % | |||
| Shares Owned By Institutions | 35.65 % | |||
| Price To Book | 43.18 X | |||
| Price To Sales | 34.69 X | |||
| Revenue | 5.28 M | |||
| Gross Profit | 7.71 M | |||
| EBITDA | (25.52 M) | |||
| Net Income | (28.62 M) | |||
| Cash And Equivalents | 24.15 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 5.64 M | |||
| Debt To Equity | 5.02 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (17.14 M) | |||
| Earnings Per Share | (0.67) X | |||
| Number Of Employees | 44 | |||
| Beta | 2.16 | |||
| Market Capitalization | 162.24 M | |||
| Total Asset | 56.65 M | |||
| Z Score | 16.8 | |||
| Net Asset | 56.65 M |
About GenSight Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GenSight Biologics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GenSight Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GenSight Biologics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GenSight Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GenSight Biologics' short interest history, or implied volatility extrapolated from GenSight Biologics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GenSight Biologics SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for GenSight Pink Sheet analysis
When running GenSight Biologics' price analysis, check to measure GenSight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenSight Biologics is operating at the current time. Most of GenSight Biologics' value examination focuses on studying past and present price action to predict the probability of GenSight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenSight Biologics' price. Additionally, you may evaluate how the addition of GenSight Biologics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |